VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
0.5566
-0.0030 (-0.55%)
Feb 9, 2026, 3:33 PM EST - Market open
VYNE Therapeutics Market Cap
VYNE Therapeutics has a market cap or net worth of $18.53 million as of February 9, 2026. Its market cap has decreased by -52.96% in one year.
Market Cap
18.53M
Enterprise Value
-14.26M
1-Year Change
-52.96%
Ranking
Category
Stock Price
$0.56
Market Cap Chart
Since March 10, 2020, VYNE Therapeutics's market cap has decreased from $229.74M to $18.53M, a decrease of -91.94%. That is a compound annual growth rate of -34.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 18.63M | -3.53% |
| Dec 31, 2025 | 19.31M | -60.93% |
| Dec 31, 2024 | 49.42M | 51.96% |
| Dec 29, 2023 | 32.52M | 273.57% |
| Dec 30, 2022 | 8.71M | -84.05% |
| Dec 31, 2021 | 54.59M | -79.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jupiter Neurosciences | 20.64M |
| Anebulo Pharmaceuticals | 20.56M |
| Polyrizon | 20.47M |
| IN8bio | 19.43M |
| CASI Pharmaceuticals | 19.00M |
| NanoViricides | 18.98M |
| Lexaria Bioscience | 18.04M |
| Klotho Neurosciences | 17.66M |